Alvotech (ALVO) vs Perrigo Company plc (PRGO)

Alvotech and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc is the larger, with a market value of $2.2B against $1.8B — 1.2× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against −4.47%. Perrigo Company plc has the higher net margin (−43.3% vs −101.1%) and the lower return on invested capital (−19.0% vs 0.00%). Across the 16 metrics below, Alvotech leads on 8 and Perrigo Company plc on 8.

Valuation

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 4.60 0.53 2.08
P/B n/m 0.89 1.79
Price to free cash flow n/m 12.39 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 8.56 1.23 2.87
Earnings yield (26.12%) (81.40%) (15.94%)
Free cash flow yield (15.71%) 8.07% 0.00%

Profitability

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 32.33% 53.51%
Operating margin (42.43%) (39.43%) 0.00%
Net margin (101.05%) (43.27%) (2.45%)
Free cash flow margin 0.00% 4.11% 0.00%
Return on equity 0.00% (51.39%) (0.80%)
Return on assets 0.00% (20.15%) (1.67%)
Return on invested capital 0.00% (19.03%) 0.00%

Growth

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% (4.47%) 5.22%
EPS growth (last fiscal year) 111.49% (723.20%) 42.91%
Revenue growth, 5-year CAGR — 0.79% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 1.35 0.04
Current ratio 1.65 2.35 2.41
Net debt to EBITDA 9.71 (4.01) 1.01

Dividend

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Dividend yield — 7.41% 1.45%
Payout ratio — — 0.27

Size

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Market cap 1.78b 2.18b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack